Realize the Current Situation of COPD Patients in China - REAL

Study identifier:D2287R00114

ClinicalTrials.gov identifier:NCT03131362

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

REALizing and Improving Management of Stable COPD in China--A Multi-centre, Prospective, Observational Study to Realize the Current Situation of COPD Patients in China.

Medical condition

Chronic Obstructive Pulmonary Disease COPD

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

5020

Study type

Observational

Age

N/A

Date

Study Start Date: 30 Jun 2017
Primary Completion Date: 06 Aug 2020
Study Completion Date: 06 Aug 2020

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jan 2022 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria